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Abstract
Background: Interventions aimed at reducing maternal mortality are increasingly complex. Understanding how
complex interventions are delivered, to whom, and how they work is key in ensuring their rapid scale-up. We
delivered a vital signs triage intervention into routine maternity care in eight low- and middle-income countries
with the aim of reducing a composite outcome of morbidity and mortality. This was a pragmatic, hybrid
effectiveness-implementation stepped-wedge randomised controlled trial. In this study, we present the results
of the mixed-methods process evaluation. The aim was to describe implementation and local context and
integrate results to determine whether differences in the effect of the intervention across sites could be explained.
Methods: The duration and content of implementation, uptake of the intervention and its impact on clinical management
were recorded. These were integrated with interviews (n= 36) and focus groups (n= 19) at 3months and 6–9months after
implementation. In order to determine the effect of implementation on effectiveness, measures were ranked
and averaged across implementation domains to create a composite implementation strength score and then
correlated with the primary outcome.
Results: Overall, 61.1% (n= 2747) of health care providers were trained in the intervention (range 16.5% to 89.2%) over a
mean of 10.8 days. Uptake and acceptability of the intervention was good. All clusters demonstrated improved availability
of vital signs equipment. There was an increase in the proportion of women having their blood pressure measured
in pregnancy following the intervention (79.2% vs. 97.6%; OR 1.30 (1.29–1.31)) and no significant change in referral rates
(3.7% vs. 4.4% OR 0.89; (0.39–2.05)). Availability of resources and acceptable, effective referral systems influenced health
care provider interaction with the intervention. There was no correlation between process measures within or between
domains, or between the composite score and the primary outcome.
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Conclusions: This process evaluation has successfully described the quantity and quality of implementation.
Variation in implementation and context did not explain differences in the effectiveness of the intervention
on maternal mortality and morbidity. We suggest future trials should prioritise in-depth evaluation of local
context and clinical pathways.
Trial registration: Trial registration: ISRCTN41244132. Registered on 2 Feb 2016
Keywords: Implementation strength, Hybrid trial, Complex intervention, Global health, Maternal mortality
Background
Despite recent advances, 800 women die every day in
pregnancy and childbirth, 99% of which are in low- and
middle-income countries (LMIC) [1, 2]. The leading
causes of death are haemorrhage, hypertensive disorders
and sepsis [2], the majority of which can be prevented
with established, cost-effective interventions [3]. Yet, in
LMIC, challenges such as inadequate numbers of trained
health care providers (HCP) [4] and insufficient access
to reliable, accurate, equipment to monitor vital signs
[5–8] lead to delays in identifying women with preg-
nancy complications which contributes to preventable
mortality and morbidity [9, 10]. Current priorities of
the global health community include combining single
effective interventions into packages of care, alongside
strategies to improve uptake, coverage and sustainabi-
lity of these interventions [11, 12].
The success of any intervention is dependent on its
use in a specific environment and population [13].
Understanding the most effective routes to deliver these
complex interventions and how they may work in va-
rying local contexts is key [14]. Randomised controlled
trials (RCT) are often criticised for providing little in-
formation about why and how an intervention worked
(or not) and the context within which it was delivered
[15, 16]. This limits the reproducibility of findings.
Sound interventions may be rejected if shown to be in-
effective. Knowing which components of an intervention
and their delivery are necessary to produce an effect in a
certain population is vital for results to be reproduced,
adapted or scaled up. This is of even greater importance
in low-resource countries with high burden of disease.
Guidance exists on how to evaluate implementation
alongside effectiveness [14, 17, 18], integrating mixed-
methods to evaluate how well an intervention was
delivered, to whom, in which context and how it may
work [18]. Hybrid effectiveness-implementation trials
aim to evaluate implementation alongside effective-
ness [19]. Whilst this methodology is established in
the evaluation of health promotion and public health
interventions, its application in maternal health in
low-resource settings is scarce [20] and few studies
are planned [21–25].
The CRADLE-3 trial was a pragmatic, stepped-wedge
RCT of a novel vital signs device and training package
introduced into routine maternity care, in ten clusters
across Ethiopia, India, Haiti, Malawi, Sierra Leone,
Uganda, Zambia and Zimbabwe with the of aim re-
ducing a composite outcome maternal death, emergency
hysterectomy and eclampsia [26]. The trial was accom-
panied by a nested mixed-method process evaluation
which was informed by the Medical Research Council
guidance for complex interventions [18]. The CRADLE
Vital Signs Alert (VSA) accurately measures blood pres-
sure (BP) and heart rate, calculates shock index (heart
rate divided by systolic BP) [27–30] and displays results
on a traffic light early warning system which indicates
abnormal vital signs (Additional file 1: Figure S1) [31].
This is important in LMIC where routine clinical tasks,
such as vital signs measurement, are often undertaken
by those with minimal training, and community health
workers also play a vital role in maternity care, often
being the first point of contact and an essential link to
clinical services [11, 32].
It was hypothesised that better availability of equip-
ment would improve the efficiency and capacity of HCP
to monitor vital signs. It was also hypothesised that
training would improve HCP understanding of when
and how to measure vital signs and how to identify and
manage pregnancy complications. The ease of use of the
CRADLE VSA and the traffic light early warning system
would mean that all cadres of HCP would be alerted to
abnormal vital signs. Together, this would result in more
women receiving more vital signs measurements, so ab-
normal results would be identified earlier and managed
faster, thus reducing maternal morbidity and mortality.
These hypotheses were developed through field studies,
stakeholder engagement and literature demonstrating
need for improved access to equipment [5–8] training in
detection and management of pregnancy complications
[33–35] and task-sharing [36, 37] in maternity care in
low-resource settings. In addition, qualitative evaluation
[31] and a mixed-methods feasibility study [38] deter-
mined that the device is robust and easy to use by any
cadre of HCP and that the training package and imple-
mentation strategy were acceptable and had potential to
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impact on clinical management (escalation and referral).
A logic model was created (Fig. 1) to present these
assumptions, processes and anticipated outcomes. This
informed the key areas for evaluation in this study.
Our aim was to describe the implementation of the
intervention and the local contexts in which it was deliv-
ered and to determine whether differences in the effect
of the intervention on the primary outcome can be
explained. This can be divided into several objectives
informed by the RE-AIM framework [15, 39]. These
were chosen with the aim of exploring if and how this
pragmatic intervention impacted on routine maternity
care in a wide variety of settings:
 To evaluate whether the intervention was
implemented as outlined in the protocol by
describing the quantity and quality of training in
each setting.
 To determine the reach of the intervention by
evaluating the extent to which health care
professionals and women were exposed to the
intervention.
 To explore how the intervention was adopted into
routine maternity care, whether this changed over
time and the potential sustainability of this.
 To explore differences in context, implementation,
reach and adoption between sites and determine
whether they can explain differences in the effect of
the primary outcome in different settings.
 To explore if and how the intervention impacted on
routine maternity care across the facilities in each
setting and identify possible reasons for this.
Methods
Intervention
The intervention comprised the CRADLE VSA delivered
through a one-off interactive training session of CRADLE
Champions. These were purposely selected HCP from
each ward or facility in the trial cluster. They were se-
lected prior to implementation, either as managers and/or
as influential in their clinical area by the local research
team. Interactive training sessions covered the use and
maintenance of the device and suggested clinical manage-
ment in response to abnormal vital signs using presen-
tations, demonstration, practice and clinical scenarios.
The CRADLE Champions were provided with posters,
training manuals and a short, animated training film (sent
by Bluetooth to smartphones). The CRADLE Champions
then used these materials to provide ongoing training and
support in their clinical area. These components of the
intervention and implementation were developed during a
6-month feasibility phase with input from stakeholders
[38]. The local research team continued to provide
regular support to all facilities with at least monthly
contact. Existing equipment for measuring vital signs
was usually removed from clinical use, unless it had a
specific function such as automation for high dependency.
Fig. 1 Logic model for the CRADLE intervention
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This intervention was compared to routine maternity care
using locally available medical devices and management
guidelines [26, 40].
Design and setting
Each cluster comprised at least one urban or peri-urban
secondary or tertiary health facility that provided com-
prehensive emergency obstetric care with multiple pe-
ripheral facilities that refer to the central hospital [26].
The stepped-wedge design meant that clusters crossed
over from control to the CRADLE intervention in one of
nine steps at two monthly intervals over the 20-month
trial duration. The order of steps was randomly allocated
using a computer-generated sequence [26]. This de-
sign was chosen to minimise the risk of bias and show
causality, should a significant effect of the intervention
be demonstrated.
Population
All HCP working in maternity care in the cluster facilities
had access to the intervention including community HCP
in two clusters where they were active in routine maternity
care and approved for inclusion (Ndola and Cap Haitien).
All women identified as pregnant or within 42 days of
delivery, that presented to routine maternity care, were
exposed to the intervention without exclusion.
Outcomes
The primary outcome was a composite of at least one of
maternal death, eclampsia or emergency hysterectomy
per 10,000 deliveries. The implementation and impact of
the intervention in each site was evaluated by mixed-
methods under three implementation domains as shown
in Fig. 2, informed by the RE-AIM framework [15, 18, 41].
We identified potential ways in which the intervention
may be working, and the necessary resources and actions
required for this, then selected measures that were
important but feasible to collect within this pragmatic,
multi-centre trial design [38].
Data collection
Baseline data were collected from each facility on the dis-
tance from the nearest tertiary referral hospital; number of
HCP working in maternity (doctors, nurses, midwives,
Fig. 2 Implementation domains and methods of data collection. Asterisk denotes quantitative measure included in the ranking analysis. HCP
health care provider, BP blood pressure, VSA Vital Signs Alert
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clinical officers and community HCP in Ndola and Cap
Haitien); availability of existing BP equipment; blood
transfusion services; intensive care beds; and magnesium
sulfate. These were selected as markers of health system
context that were important and feasible to measure. This
was updated a minimum of three times during the trial
period. Major changes to the political or physical environ-
ment such as infrastructure, staff retention and extreme
weather conditions were evaluated monthly. The number
of deliveries in each cluster was collected by review of
facility registers and routine reporting. Community deli-
veries were captured through a variety of methods such as
household visits from community health workers in India
and monthly reporting meetings with traditional birth
attendants in Haiti (three sites did not routinely record
deliveries that occur outside of facilities).
Training was observed against a pre-defined observa-
tional checklist, including the number of training days
and the proportion of core content delivered. Training
registers were completed and compared to staffing num-
bers. All clusters reported at six monthly intervals on
the proportion of clinical areas using the CRADLE VSA
device. In order to evaluate the ways in which the inter-
vention, and participants interaction with it, may trigger
change (mechanisms of action) [38], the number of
women attending maternity services, the proportion that
had their BP measured and the proportion referred to
higher level care were measured for a 4-week period
immediately prior to implementation and 3months after
implementation. This was integrated with qualitative
findings on context and use of the device.
In each site, we undertook semi-structured interviews
(n = 3–5) and focus group discussions (n = 1) with HCP,
3 months after implementation. These explored the
uptake of the intervention, its influence on clinical ma-
nagement and any unexpected consequences. In sites that
implemented in the first 14months of the trial, a further
focus group discussion was undertaken at 6–9months
after implementation to explore whether influence on
clinical management, escalation and referral systems
changed over time and the sustainability of the inter-
vention. In total, we conducted 36 interviews and 19
focus group discussions with 130 participants across
the ten sites. Participants were selected through pur-
posive sampling to ensure representation of different
HCP cadres and facilities. Participants were approached
face-to-face and gave written informed consent. These
were recorded, and transcribed verbatim and field notes
were recorded. Content and notes were reviewed itera-
tively to identify further participants until data saturation
was achieved. All qualitative work was undertaken, trans-
lated and transcribed by experienced local research co-
ordinators (with clinical background) following training
from the trial coordinator and senior social scientist (JS)
or qualitative researchers. Researchers had limited prior
relationship with the participants. Two data coders that
were independent to the interviewers undertook initial
analysis using QSR NVivo 11 software (QRS, Vic,
Australia) prior to revealing the analysis of the primary
outcome then further analysis once the results were
known. We used the framework method with a coding
framework that drew upon the study objectives, logic
model and interview guide [42, 43]. New concepts ini-
tiated by participants that could not be categorised were
coded using an inductive approach [44].
In order to compare implementation and determine
whether this was related to effectiveness, we used a
ranking approach as previously described in other fields
[45–47]. Clusters were ranked from highest to lowest on
selected quantitative outcomes on implementation fidelity,
reach and adoption (marked by an asterisk Fig. 2). These
were selected as the direction of benefit was clear, whereas
the anticipated direction of change for outcomes on con-
text and action were less clear (e.g. poorer availability of
resources at the trial start may be associated with greater
benefit from the intervention due to greater need, or less
benefit due to inability to respond to abnormal vital signs).
Outcomes under the same domain were averaged and
converted to a possible range (0 to 1) to give each cluster
a score for each domain analysed (implementation fidelity,
reach and adoption). These were then averaged to give
each cluster a single composite score reflecting their
implementation (possible range 0–1) [45–47]. Due to
the stepped-wedge design, the single measure of adop-
tion was only available in eight of the ten sites. The
individual domain scores and overall composite score
were compared to primary outcome in each site. Corre-
lation between the individual measures within domains
was also determined [48].
Statistical analysis
Statistical analyses were undertaken in Stata version
14.2. For the primary outcome in individual sites, the
main analysis used logistic regression with generalised
estimating equations and a population-averaged model.
Adjustments were made for fixed centre effects (catego-
rical) and separate fixed linear trends (continuous) in
each centre to account for changes in the primary out-
come over time [49]. Results are reported as odds ratios
(ORs). Details of randomisation and further analysis of
the trial are published in protocol [26] and primary re-
sults paper [50]. For the evaluation of implementation,
the ranks were summarised, and simple rank corre-
lations calculated. We used meta-regression to see if the
primary outcome in individual sites were related to the
individual and composite implementation scores [51].
For comparison of referral rates before and after imple-
mentation, unadjusted OR were calculated and combined
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using random effects meta-analysis [52]. In each site a
4-week period immediately prior to and 3months after
implementation were compared; this is a non-randomised
comparison.
Results
Implementation fidelity
The average duration of implementation training across
all facilities was 10.8 days (range 7 days in Addis Ababa to
18 days in Mbale). In total, 2747 HCP were trained, 61.1%
of all those working in maternity services in those sites
(range 16.5 in Kampala, Uganda to 89.2% in Zomba,
Malawi, Table 1). Nine of the ten sites delivered all the key
content of training. Freetown, Sierra Leone was the first to
implement with less emphasis on training senior staff, the
background of device development and validation studies.
Following challenges from senior staff in accepting device
accuracy, this was emphasised in subsequent site training.
Educational materials were translated (India, Ethiopia,
Malawi, Haiti), and delivery was adapted to take into ac-
count locally available medications and referral structures.
In India, all training was delivered by the research team
rather than via CRADLE champions (87.1% trained). In
Haiti, community HCP without formal training had a
longer duration of training (approximately 2 days), spen-
ding more time checking understanding. The duration of
training was longer in sites with a wider geographical
spread or more challenging terrain (Mbale, Uganda; 18
days and Zomba, Malawi; 16 days) except in India,
which was able to mobilise a larger local research team
(10 days). External events influenced implementation in
two sites. One of three tertiary hospitals in Cap Haitien,
Haiti was closed at the time of implementation due to
strike action, therefore key managers were trained, and
remaining staff received training within 2 weeks of
opening. In Ndola, Zambia, implementation coincided
with roll-out of alternative (un-related) training for
Table 1 Quantitative implementation measures of implementation fidelity and reach
Implementation Reach Adoption
Site Staff trained in
roll-out period
Proportion
of women
with BP
measurement
pre-interventionψ
Proportion
of women
with BP
measurement
post-
interventionψ
Unadjusted
comparison
Facilities
with
working BP
pre-
intervention
Facilities
with
working BP
post-
intervention
Clinical
areas
using
solely
VSA at
6 months
Clinical
areas using
VSA with
other
devices at
6 months
Clinical
areas
using
solely
VSA at
12
months
Clinical
areas
using VSA
with other
devices at
12 months
N (%) N (%) N (%) OR
(95% CI)
% (devices,
HCP)
% (devices,
HCP)
% % % %
Addis
Ababa
192 (36.9%) * * * 100%
(1:3)
100%
(1:2)
33.3% 66.7% υ υ
Cap
Haitien
189 (73.5%) * * * 100%
(1:3)
100%
(1:3)
76.2% 23.8% υ υ
Freetown 243 (57.9%) 2199 (87.7%) 3335 (100%) 1.14
(1.12–1.16)
84·6% (1:13) 100%
(1:4)
73.1% 26.9% 96.2% 0.0%
Gokak 297 (87.1%) * * * 97·5%
(1:1)
100% (1:0.7) 72.3% 27.7% υ υ
Harare 405 (69.9%) * * * 92%
(1:12)
100%
(1:5)
υ υ υ υ
Kampala 188 (16.5%) * * * 92.3% (1:19) 100%
(1:4)
33.8% 47.9% 34.2% 47.9%
Lusaka 265 (33.9%) * * * 100%
(1:10)
100%
(1:5)
75.9% 24.1% υ υ
Mbale 314 (59.2%) 4640 (42.6%) 11,300
(96.2%)
2.26
(2.21–2.31)
92%
(1:5)
100%
(1:2)
87.3% 9.9% υ υ
Ndola 349 (86.6%) 5673 (98.2%) 5782 (100%) 1.02
(1.0–1.2)
93.5%
(1:7)
100%
(1:2)
90.2% 9.8% 90.2% 9.8%
Zomba 305 (89.2%) 11,860 (88.4%) 10,783
(94.1%)
1.06
(1.06–1.07)
100%
(1:17)
100%
(1:2)
υ υ υ υ
Total/
Mean
2747 (61.1%) 6093 (79.2%) 7800 (97.6%) 1.30
(1.29–1.31)
95%
(1:9)
100%
(1:3)
73.1% 23.3% 73.5% 20.0%
*Data not recorded; BP blood pressure, VSA Vital Signs Alert
υData not available due to stepped wedge trial design (time point exceeded trial duration)
ψRecorded for a 1-month period immediately prior to implementation, and a 1-month period 3 months after implementation
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some maternity staff by the Ministry of Health. Imple-
mentation went ahead as planned for remaining staff, and
those that were unable to attend were trained by cham-
pions or the research team in the subsequent week.
Clusters that trained fewer staff tended to have multiple,
very large facilities with high numbers of deliveries (Lusaka
and Kampala), except Freetown, which was a smaller unit
but trained fewer staff. This cluster was the first to imple-
ment, possibly demonstrating the learning curve of the
research team. Qualitative findings demonstrated that the
majority of participants from all sites felt the training was
adequate (demographic details of the qualitative partici-
pants are shown in Table 2). Champions felt confident
using the materials to orientate their colleagues. Recipients
of training from champions were confident to use the VSA
and also to orientate others. A small minority of partici-
pants from the three sites that trained the fewest HCP
(Addis Ababa, Kampala and Freetown) highlighted that
training from the champions had been brief, that staff
who were not trained took longer to learn and faced
initial challenges with use, or that ongoing training may
not be sustainable with staff turnover (quotes to illus-
trate in Table 3).
Reach
Overall, 3868 devices were delivered across 286 facilities.
Four clusters recorded the proportion of women with
BP measurement. All demonstrated a significant in-
crease in measurements made after the intervention
(usual care mean 79.2% (n = 6093/7693) vs. intervention
97.6% (n = 7800/7992); OR 1.30, 95% CI 1.29–1.31);
Table 1). Prior to the intervention, 95% of facilities had
access to at least one working BP machine. After the inter-
vention, 100% had access, with better availability per HCP
Table 2 Demographic details of interview and focus group participants
Interview participants Focus group discussion participants Focus group discussion participants
Time after implementation 3 months 3 months 6 to 9 months
Mean duration (minutes)(range) 25 (7–45) 64 (39–125) 58 (35–87)
Profession
Midwife 16 38 28
Nurses 13 23 18
Doctors 3 2 4
Clinical officers 0 1 0
Community HCP 1 4 5
Allied HCP 3 2 5
Gender
Male 5 7* 7
Female 31 57* 53
Age (years)
18–24 2 0* 0
25–34 12 24* 20
35–44 14 31* 23
45–54 6 7* 8
55–65 2 2* 9
Educational level
Secondary or less 2 8* 6
Diploma 27 47* 30
Certificate 2 5* 11
Bachelor’s degree or higher 5 4* 13
Experience (years)
1–5 12 16* 15
6–10 8 17* 13
11–15 9 16* 14
> 15 7 15* 18
*Demographic detail missing for 6 participants from one focus group discussion in Malawi
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Table 3 Selected quotes to illustrate qualitative themes
Domain Theme Qualitative quote
Fidelity Quality of training Midwife, Tertiary Hospital, Ndola, Zambia: “Sister* who had an opportunity to attend
the one-day workshop where the orientation was done (on) how to use the BP
machine and she is the one who disseminated the information, orientated myself
and other midwives from labour ward on how to use this BP machine … after I got
used I have not had any problems and I have also oriented other medical personnel
on how to use it. It has been so helpful.”
Midwife, Clinic, Addis Ababa, Ethiopia: “The apparatus is very good. But there was a
minor problem. None of us took any training, but instead we just received the
apparatus and we started putting it to use. And it had some problems on accuracy.”
Reach Better availability of equipment meant more
measurements done and on more women.
Clinical Officer, Peripheral Hospital, Zomba, Malawi: “it’s just a matter of having
enough resources now, that at least we have a BP machine in the ward and outside
to the health centers, and indeed is the easy one, is the fast one. So this is what
can take at the same time to listen to the BP. So the things I see at least is that the
BP are taking place more often, because the BP machine is always available”
Better availability of equipment reduced time
taken to monitor.
Midwife, Outpatients, Tertiary Hospital, Freetown Sierra Leone: “… with one referral
the pressure was down, it prompted us greatly, to start IV fluids, call a doctor to
come back from theatre...(details of clinical management). This machine (VSA)
helped us a lot because if it was any other machine where we use stethoscope, we
would have needed to run around trying to look for it, but that machine is already
there. That morning the machine saved her, because thank god she survived, was
discharged, and we are happy about that.”
Increased confidence resulted in increased
monitoring in facilities
Medical Officer, Primary Health Centre, Gokak, India: “Earlier, because of overload of
work our ANMs were not checking the BP with mercury apparatus. Now, after
introduction of this machine and after showing this to AHSAs also in a meeting,
they are happy with what they are doing. And they are doing more checks than
they were doing earlier. Earlier, they were sending pregnant women to the doctor,
telling them that the doctor will check the BP. But now they are also checking and
then sending the patients to me.”
Task-sharing increased monitoring in
communities
Registered Nurse, Clinic, Ndola, Zambia: “ … we had a case last month where a
SMAG member (Safe Motherhood Action Group volunteer) got BP machine to go
and visit a woman in one of the villages and she discovered that BP was high
and client referred and managed at Ndola Central Hospital. Without CRADLE that
woman would have been left to die in the community. The CRADLE VSA machine
is helping us a lot.”
Adoption Ease of use Junior midwife, Clinic, Addis Ababa, Ethiopia: “In our health center, the former
device used to fail often. This one measures both the blood pressure and pulse.
This means it helps us forecast to the future, about the condition of the woman.
Before this, we used to measure only blood pressure, and that’s it. But now since
it helps us forecast her pulse. It assesses the condition of the woman, whether
she is entering a danger zone or not. It helps us to take care of the mother
before the event. Second, since it helps us with the management during the
emergency case, it prepares us to take action immediately. So, it guides us,
it measures pulse and as long as we follow the rules of positioning, its accuracy
is also very good. I like it.”
Improved reliability and champion/research
team support
Midwife, Clinic, Addis Ababa, Ethiopia: “The devices we used before were very
prone to malfunctioning. But if this one malfunctions, it is often due to improper
usage. When such problems happen call (the research assistant) and try to solve
the problems. In general, it is helpful for our health center.”
Security Midwife, Labour Ward, Tertiary Hospital, Ndola, Zambia: “Yes we had one
experience. I think they were just introduced. One blood pressure machine
had gone missing … And from that time we learnt a lesson. So each time we
are changing shift all the equipment is put on the table and handed over.”
Mechanism of
action
Cultural change Nursing officer, Clinic, Mbale, Uganda: “it has become a quality issue to monthly
charts on how many patients had their BP taken each month since machines
are readily available for use. It has increased the work load since every mother
has to have her BP taken.”
Alerts trigger increased investigation Maternity Health Assistant, Clinic, Freetown, Sierra Leone “… we check them all
when they come and if I see those colours I call my boss. Because when the
machine shows those colours it’s a problem and we need to ask her some
questions. And if she says she’s not well I can say there is something wrong
with her. It will not show this colour if they are well. A person who is well will show
a green colour. And if it still persists for two or three times with that colour, we can
send them to do tests sometimes to detect anaemia, sometimes (haemoglobin)
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in all clusters. Participants from both clinics and hospitals
in every cluster except Haiti reported an increase in the
availability of equipment. The availability of equipment,
and its ease of use, meant that more vital signs measure-
ments could be done and faster, as staff did not spend
time looking or waiting for equipment (Table 3).
Many participants reported that students and other
allied HCP or volunteers would regularly help to take
vital signs measurements with the device. More junior
staff also took more vital signs measurements, where
they would previously have referred the patient to other
HCP for routine monitoring. This was reported to be
due to greater confidence in their capacity to measure
BP and interpret results. It was frequently commented
that this made it more likely that women would have
their vital signs measured (Table 3). In Haiti and Ndola,
community HCP reported confidence and pride in being
equipped and skilled to monitor vital signs in their com-
munity. This also led to more vital signs measurement
in the community and earlier detection of abnormalities
(Table 3). A minority of HCP reported that demand still
outweighed supply, even though this was improved.
Adoption
The majority of sites reported rapid use of the device on all
pregnant women. The reasons for rapid adoption differed
according to site context. Sites with poor availability or
poor-quality existing equipment (e.g. Kampala, Freetown,
Mbale and Zomba) reported rapid use, irrespective of the
different proportion of staff that were trained. Sites with
adequate availability of equipment prior to implementation
(Gokak and Addis Ababa) elected to use the VSA in prefer-
ence to other equipment citing ease of use, better accuracy
and easier interpretation due to the traffic light alert,
which reduced the workload. This was true across all
cadres of HCP from community volunteers to medical
officers in hospitals.
Due to the stepped-wedge design, eight clusters
reviewed use at 6 months post-implementation and three
at 12 months. The majority of clinical areas were using
solely the CRADLE VSA device at 6 months (73.1%;
range 33.3% in Addis Ababa, Ethiopia to 90.2% in Ndola,
Zambia, Table 1). Only 4.8% of clinical areas had chosen
to use previously existing vital signs devices in pref-
erence to the CRADLE device. This was still reflected at
12 months (73.5% using solely the CRADLE device). A
minority of sites reported barriers to adoption, the most
frequent was the sensitivity of the VSA to movement
and positioning, in some cases leading to mistrust of the
accuracy of results. This was reported more frequently in
sites with low fidelity (Freetown, Kampala and Addis
Ababa). However, qualitative findings in Freetown suggest
that active support from the champions or the research
team resolved this concern, and this correlated with
improved adoption compared to Addis Ababa and
Kampala and over time (Table 1).
By the trial end, 4·6% (n = 180) of VSA were reported
to be broken. The most commonly reported reasons
were failure of the battery, leaking of the valve in the
pump or tears in the cuff. Many sites noted it was more
robust than pre-existing equipment (Table 3). Very few
CRADLE VSA were reported missing by the trial end
(0·6% (n = 23). Sites described self-directed systems of
handover or registration to minimise this risk (Table 3).
Relationship with clinical outcome
The effect of the intervention on the primary outcome is
shown in Fig. 3 (Additional file 1: Table S2). After planned
Table 3 Selected quotes to illustrate qualitative themes (Continued)
Domain Theme Qualitative quote
9 grams or 8 grams. So we can treat her little by little.”
Alerts aid communication Midwife, Private Labour Ward, Ndola, Zambia: “as a midwife, as nurse you are
supposed to know the abnormal so because of that at least it has … I would not
say it has changed (management) much but sometimes yes it does help us.
When it is red we do the BP we check again, if its red it means the BP is very high
we have to inform the doctor immediately. So there are times when you would
call the doctor and they not in, you make sure you emphasize because that the
patient has to be seen soon..”
Alerts convince women and families Midwife, Clinic, Ndola, Zambia: “if it shows red, I also explain to her even showing
her to say “have you seen this colour? Where is this arrow pointing, no it is pointing
up. Yes, this means am supposed to refer you to Ndola central” but like before
when we were using the digital and the mercury we would just do and even if
the patient reads the readings to be high (they) would not understand. But this
time around since it has colours, even for somebody who is not learned, it is easy
to convince them”
Alerts motivate women Auxillary Nurse Midwife, Community Health Post, Gokak India: “The number of
those who come themselves voluntarily has increased and the awareness of getting
the BP checked has improved among them. If we show them the reading, they
think “Yes, all such things are there in the BP; we need to get checked; if it shows
yellow it means this; if it shows red it mean this, there are the signals for us”.”
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adjustment for temporal trends, significant benefit of the
intervention was shown in Freetown, Cap Haitien and
Lusaka, which included the sites with the lowest and
highest baseline primary outcome event rate (39.4/10,000
deliveries in Lusaka; 324/10,000 deliveries in Freetown).
There was also considerable variation in the implemen-
tation, reach, adoption and context between clusters with
no significant correlation between the individual measures
within any domain, including physical context. There was
no significant correlation between the randomised order
of implementation and the primary outcome.
The two clusters that trained the highest proportion of
staff with the highest content as planned in the protocol
(fidelity) were Gokak and Zomba. There was no correlation
between fidelity and effectiveness (OR 0.55; 0.19–1.55).
The two sites that had the best improvement in availability
of equipment (reach) were Freetown and Kampala. Overall,
no correlation was demonstrated between reach and effect-
iveness (OR 0.62; 0.27–1.42). The majority of facilities were
using the CRADLE VSA device either alone or in combi-
nation with another device at 6months, and this measure
(adoption) was not correlated with the primary outcome
(OR 1.40; 0.64–3.04). When domains were aggregated into
a composite score, the combination of fidelity, reach and
adoption was not significantly associated with the primary
outcome (OR 0.93; 0.07–13.01).
Context and mechanism of action
Across all clusters an average of 50.0% of deliveries
occurred in the central referral facilities (mean = 1358
per month per cluster), 45.7% in peripheral facilities
(mean = 1241 per month per cluster) and 4.3% at home
(mean = 118 per month per cluster from seven clusters
where this was systematically collected; Table 4). The
mean proportion of deliveries by caesarean section was
17% (n = 91,158/536,223; range 9–31%). The availability
of key obstetric resources and staffing levels are shown
in Table 4. In the majority of sites, one staff member (or
less) per 1000 deliveries per month joined or left the
workforce in each cluster. Availability of magnesium sul-
fate and blood transfusion services changed in less than
2% of facilities per month in all clusters. The measures
of physical context were variable between and within
sites. Lusaka, Zomba and Kampala had the fewest total
staff per 1000 deliveries. The lowest proportion of
caesarean deliveries were done in Lusaka (9%) and Ndola
(10%). Ndola also had the lowest proportion of facilities
with blood transfusion capacity (6.5%), and Cap Haitien
had the fewest facilities with magnesium sulfate (25%).
There were a number of external influences during the
trial period, for example strike action in Kampala,
Uganda and an earthquake outside of the research area
in Haiti. However, sites reported minimal impact of
these events on care provisions.
In addition to the mechanisms previously described
(better availability of equipment, ease of use and confi-
dence of all cadres of HCP to measure vital signs), the
increase in equipment and training meant it was no longer
acceptable to not measure vital signs on every woman.
Staff reported increased motivation and interest in vital
Fig. 3 Forest plot showing odds ratio for primary outcome in individual clusters in the intervention period compared to the control period
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signs measurements. Only one site (Mbale) reported this
in a negative light, since measurement of BP on all women
increased workload. The other sites reported a reduced
workload as time taken to find equipment, measure vital
signs and interpret results was reduced, and this task
could be undertaken by a wider number of HCP.
It was frequently reported that the intervention
prompted HCP to do more investigations, more quickly.
This was reported to be because the traffic light display
alerted users to results outside the normal range, and
HCP had more confidence in the results so were better
able to make decisions. This finding was not dependent
on the number or skill level of staff. A minority of par-
ticipants opposed this view, stating that the management
was unchanged, as vital signs were always measured and
acted upon. This was most commonly reported by senior
HCP working in better-resourced environments. Even in
this setting, benefit was still reported from the traffic
light alert in aiding communication between HCP.
The majority of sites also reported that the alerts were
easily understood by women and untrained staff such as
ambulance drivers. This was beneficial in conveying the
need for management or referral, especially in sites
where this was reported to be a key barrier to care
(Gokak, Ndola, Zomba, Harare). Some sites reported
that increased awareness of vital signs in the community
resulted in increasing demand for measurements to be
done (Table 3).
The impact on referrals differed between sites. Overall,
3.7% (n = 2784/74,828) of women seen in peripheral ma-
ternity facilities were referred to higher level care in the
control period compared to 4.4% (n = 3212/73,371) in the
intervention period (OR 0.89; 0.39–2.05) (data for nine
sites that were able to collect denominator). However, the
majority of sites demonstrated a small but significant re-
duction in referrals with a single site (Gokak) demonstra-
ting a 16-fold increase (Fig. 4, Additional file 1: Table S1).
Qualitative findings suggest the increase in Gokak was a
result of increased community monitoring, increased
confidence in peripheral HCP to detect abnormal vital
signs and convince women to attend, alongside rigor-
ous adherence to referral protocols from rural health
posts (subcentre) to primary care centres, meaning all
women with asymptomatic anaemia triggering a yellow
light were referred. This is in combination with an
effective ambulance system, and further systems in
place to cope when ambulance services were delayed,
to transfer patients from primary care clinic to hospital
when acute complications were detected. Therefore, the
wide geographical distance (mean 74 km from peripheral
clinic to tertiary hospital) of this site did not impede
delivery of care.
In contrast, Haiti reported no change in the number
of referrals but that abnormal vital signs were detected
and referred faster by using the traffic light alerts to con-
vince women to attend, where cultural acceptability and
Fig. 4 Forest plot showing odds ratio for referral in individual clusters (Data for nine sites that were able to collect denominator data.
Data collected for a 4-week period immediately prior to and 3 months after implementation) in the intervention period compared to the
control period
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perceived quality of hospital care was a barrier. However,
despite the relatively small cluster size (mean 14 km
from peripheral clinic to tertiary hospital), the qualitative
data indicated that the lack of ambulance service or
funds (personal or within the health care facility) to pay
for transport led to long delays contributing to morbi-
dity and mortality, irrespective of the capacity to moni-
tor and escalate care peripherally.
Differing acceptability of referrals and the relationship
between peripheral and tertiary facilities arose as import-
ant contextual themes that may have facilitated or im-
peded action from the intervention. For example, HCP
in Lusaka (significant benefit of the intervention) de-
scribed an existing mechanism for constructive feedback
on referrals between facilities, which was aided by the
introduction of uniform monitoring equipment. In com-
parison, HCP from both peripheral and tertiary facilities
in Zomba (no benefit of intervention) described negative
concerns about referral, such as a lack of system to alert
the recipient hospital of the pending transfer resulting in
patients being refused admission. HCP in peripheral
facilities in Mbale (no benefit of intervention) reported
that referrals were reduced following the intervention,
since pre-eclampsia could now be managed in the com-
munity, which was encouraged by the tertiary facility.
Discussion
This paper describes the mixed-methods evaluation of
implementation alongside a pragmatic, stepped-wedge
RCT in ten low- and middle-income sites. We have
demonstrated that the CRADLE intervention was deliv-
ered appropriately. All clusters demonstrated improved
availability of vital signs equipment after the interven-
tion, with increased vital signs measurements in both
our quantitative and qualitative analysis. Acceptability of
the intervention was good as shown by the high propor-
tion of facilities using the device at 6 and 12months
after implementation and triangulated with the qualita-
tive findings. Referral rates were reduced in the majority
of clusters which correlated with qualitative findings.
Overall, we have shown no correlation between process
measures within domains and no correlation between
individual domains and the primary outcome.
Implementation fidelity varied between sites. As this
was a pragmatic trial, it was prospectively decided that
whilst fidelity would be measured, it would not be used to
address and change implementation problems during the
trial. This was to ensure generalisability of trial findings in
future scale-up, which would likely have limited capacity
for detailed monitoring and feedback. The balance
between delivering an intervention with high fidelity
and adapting to context is widely recognised [18]. We
adhered to specific components of training to ensure that
delivery was similar across eight countries. However, we
demonstrated that it was possible to adapt the delivery
model of training whilst maintaining a high proportion of
training (as described above for Gokak, India where the
research team led all training).
Examples of studies that explain the selection of
implementation measures and analyse them alongside
primary outcomes are scarce, especially in low-resource
settings within the confines of limited infrastructure,
research capacity and funds. This paper demonstrates
that evaluation of simple implementation process mea-
sures alongside a large-scale pragmatic trial is feasible
and useful in describing the quality and quantity of
implementation in different sites and exploring the poten-
tial mechanisms of impact. This methodology provides
valuable learning for future research in LMIC by pro-
viding information to inform implementation strategies
and scale-up.
Research in other fields (e.g. school education) has dem-
onstrated that higher implementation fidelity is associated
with better programme outcomes [53]. We have not
shown any correlation with the primary outcome. This
trial was powered for the primary composite outcome, not
the process outcomes. Therefore, it is possible there was
insufficient power to detect a significant relationship, as
suggested by the wide confidence intervals. It is also pos-
sible that this is due to the validity of the process mea-
sures themselves or their combination within domains. In
the example of reach, the measurement of women that do
not attend health services, and were therefore not ex-
posed to the intervention, was not possible. Instead, a
surrogate measure of change of equipment availability
was selected. It could be argued that clusters with bet-
ter resources were most likely to demonstrate benefit
due to their capacity to respond. Alternatively, those
with poor baseline resources may benefit most from the
increase in equipment availability. Measuring exactly
how an intervention may exert its effect in different set-
tings is challenging within a pragmatic trial of this size.
In addition, to minimise the burden of data collection
only a few of the many potentially relevant domains
could be assessed, and some single items were used to
measure some domains. Future research should explore
the relationship between implementation strength and
trial outcomes and approaches to integration of data.
A further possible reason is the validity of the primary
outcome measure in individual sites. As this is a
stepped-wedge RCT, the analysis of individual sites’ data
is subject to external factors and temporal trends. Whilst
these were adjusted for, the variation between and within
sites was greater than anticipated and seasonal trends
were evident which could not be adjusted for. Due to
the scale and setting of the trial, other outcomes such as
diagnosis of pre-eclampsia or sepsis were not collected.
Despite this, the validity of the CRADLE VSA as an
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accurate, robust, useful tool is maintained. Mixed-
method follow-up of use of the device at 6months to 1 year
after implementation is a strength of this study and sup-
ports the sustainability of the intervention. In addition, the
proportion of devices that were broken or missing was
lower than our sites report for previous existing equipment.
Adoption was greater in sites that had higher proportions
of HCP trained or more active CRADLE champions or
local research teams to support the device. This suggests
that these would be important factors for future scale-up.
The strengths of this study are the predefined choice
of theoretically-based, predominantly objective, quantita-
tive measures to test hypothesised mechanisms of action.
Additional strengths are the integration of qualitative
and quantitative measures to triangulate findings and
the pragmatic approach to data collection from many
routine data sources. Funding restrictions meant the
process evaluation and implementation were led by the
same research team. This is a possible source of bias,
although efforts were made to reduce this by under-
taking the initial framework and qualitative analysis
prior to analysis of the primary outcome. Whilst the
diverse settings of this trial are a strength, the number
of sites, resource constraints and the simultaneous
delivery alongside a stepped-wedge trial design (with strict
intervals for implementation) meant that there was
limited capacity to collect additional data in response to
early findings.
The success of the intervention is dependent on HCP
capacity to change clinical management, particularly in
response to an abnormal result. The physical and geo-
political environment within which the intervention is
delivered is therefore key. A recent systematic review
identified that just 41 RCTs undertaken in sub-Saharan
Africa across all health specialities describe any element of
context [54]. This study selected a number of quantitative
measures of health system infrastructure similar to others
in the field [12, 55] and combined this with qualitative
review of clinical management and referral pathways.
However, these simple measures inadequately described
the complexities of these multiple health systems, their
clinical pathways and readiness for change [56, 57].
Conclusions
Evaluation of implementation and integration of results
with health outcomes is recommended by the Medical
Research Council [18], yet there is insufficient guidance or
example of a suitable methodology. To our knowledge,
this is the first implementation process evaluation along-
side an effectiveness trial that has evaluated implementa-
tion using a mixed-methods approach and integrated
these with the primary outcome with the aim of under-
standing differences between multiple low-resource
sites. We have demonstrated the successful selection of
measures to describe implementation and explore
mechanism of action that were feasible. However, the lack
of correlation within domains and with the primary out-
come suggest that future trials should consider taking fur-
ther account of the ability of sites to respond, particularly
when considering trials of diagnostic tests rather than
direct therapeutic interventions. Measurement across all
sites was necessary for comparison of implementation.
Future research should consider the addition of in-depth
analysis in a restricted selection of sites, for example, into
clinical care pathways and factors that inform decision-
making and deviation from protocols, to explain the effect
of complex interventions.
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